2025-03-12 12:50:47
Latest Post
W S Industries India Ltd's subsidiary to acquire 54.89 acres land for Rs. 46.66 crores
IKS Health wins Top Honors in 2025 Black Book Survey in New AI-Driven RCM Category
Mipco Seamless Rings Gujarat Ltd approves shifting of registered office
Crizac Limited gets Sebi Nod for Rs 1,000 cr IPO
REC Limited inaugurates REC Experience Center
Stock Report
Suven Life Sciences reports consolidated loss of Rs. 33.69 crores in Q3FY22
Posted On : 2022-01-31 13:09:39( TIMEZONE : IST )
Suven Life Sciences Limited has reported Consolidated financial results for the period ended December 31, 2021.
Financial Results (Q3 FY2022) - QoQ Comparison
The company has reported total income of Rs. 4.5738 crores during the period ended December 31, 2021 as compared to Rs. 1.6869 crores during the period ended September 30, 2021.
The company has posted net profit / (loss) of Rs. -33.6903 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs. -28.2982 crores for the period ended September 30, 2021.
The company has reported EPS of Rs. -2.65 for the period ended December 31, 2021 as compared to Rs. -2.22 for the period ended September 30, 2021.
| Financials | Q3 FY2022 | Q2 FY2022 | % Change |
| Total Income | ₹4.5738 crs | ₹1.6869 crs |  171.14% |
| Net Profit | ₹-33.6903 crs | ₹-28.2982 crs |  19.05% |
| EPS | ₹-2.65 | ₹-2.22 | 19.37% |
Financial Results (Q3 FY2022) - YoY Comparison
The company has reported total income of Rs.4.5738 crores during the period ended December 31, 2021 as compared to Rs.3.1371 crores during the period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-33.6903 crores for the period ended December 31, 2021 as against net profit / (loss) of Rs.-24.3929 crores for the period ended December 31, 2020.
The company has reported EPS of Rs.-2.65 for the period ended December 31, 2021 as compared to Rs.-1.92 for the period ended December 31, 2020.
| Financials | Q3 FY2022 | Q3 FY2021 | % Change |
| Total Income | ₹4.5738 crs | ₹3.1371 crs | 45.80% |
| Net Profit | ₹-33.6903 crs | ₹-24.3929 crs | 38.12% |
| EPS | ₹-2.65 | ₹-1.92 | 38.02% |
Financial Results (9 Months Ended FY2022) - YoY Comparison
The company has reported total income of Rs.12.8220 crores during the 9 Months period ended December 31, 2021 as compared to Rs.18.3518 crores during the 9 Months period ended December 31, 2020.
The company has posted net profit / (loss) of Rs.-101.1970 crores for the 9 Months period ended December 31, 2021 as against net profit / (loss) of Rs.-50.5388 crores for the 9 Months period ended December 31, 2020.
The company has reported EPS of Rs.-7.95 for the 9 Months period ended December 31, 2021 as compared to Rs.-3.97 for the 9 Months period ended December 31, 2020.
| Financials | 9 Months Ended FY2022 | 9 Months Ended FY2021 | % Change |
| Total Income | ₹12.8220 crs | ₹18.3518 crs |  -30.13% |
| Net Profit | ₹-101.1970 crs | ₹-50.5388 crs | 100.24% |
| EPS | ₹-7.95 | ₹-3.97 | 100.25% |
Shares of Suven Life Sciences Limited was last trading in BSE at Rs. 89.30 as compared to the previous close of Rs. 88.55. The total number of shares traded during the day was 34871 in over 991 trades.
The stock hit an intraday high of Rs. 91.55 and intraday low of 88.45. The net turnover during the day was Rs. 3143518.00.
